Medical Marijuana, Inc. (MJNA)
OTCMKTS
· Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
Nov 1, 2024, 3:53 PM EDT
Medical Marijuana Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | 2014 - 2012 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '20 Jun 30, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | 2014 - 2012 |
| Operating Revenue | 58.98 | 75.56 | 59.83 | 26.52 | 8 | 9.22 | Upgrade
|
| Revenue | 58.98 | 75.56 | 59.83 | 26.52 | 8 | 9.22 | Upgrade
|
| Revenue Growth (YoY) | -20.71% | 26.30% | 125.56% | 231.37% | -13.15% | -36.55% | Upgrade
|
| Cost of Revenue | 12.5 | 17.83 | 19.49 | 8.11 | 3.37 | 3.91 | Upgrade
|
| Gross Profit | 46.48 | 57.73 | 40.34 | 18.41 | 4.64 | 5.3 | Upgrade
|
| Selling, General & Admin | 46.74 | 54 | 48.36 | 22.65 | 8.47 | 8.27 | Upgrade
|
| Research & Development | 0.2 | 0.43 | - | - | - | - | Upgrade
|
| Operating Expenses | 48.7 | 56.31 | 49.88 | 23.43 | 9.05 | 9.3 | Upgrade
|
| Operating Income | -2.22 | 1.42 | -9.54 | -5.02 | -4.42 | -3.99 | Upgrade
|
| Interest Expense | -0.99 | -1.09 | -1.82 | -7.02 | -11.11 | -3.05 | Upgrade
|
| Interest & Investment Income | 0.51 | 0.51 | 0.21 | 0.77 | 0 | 0.73 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.99 | 2.18 | -0.4 | - | - | -1.41 | Upgrade
|
| EBT Excluding Unusual Items | -0.71 | 3.02 | -11.56 | -11.27 | -15.53 | -7.72 | Upgrade
|
| Impairment of Goodwill | - | - | - | -130.84 | - | 129.23 | Upgrade
|
| Gain (Loss) on Sale of Investments | 9.23 | 82.24 | -189.97 | - | -9.92 | -16.4 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -73.47 | Upgrade
|
| Legal Settlements | 0.28 | -0.86 | -1.1 | -0.09 | -0.08 | -3.89 | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.83 | -1.76 | Upgrade
|
| Pretax Income | 8.8 | 84.4 | -202.63 | -142.2 | -26.36 | 25.99 | Upgrade
|
| Earnings From Continuing Operations | 8.8 | 84.4 | -202.63 | -142.2 | -26.36 | 25.99 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -5.91 | - | - | Upgrade
|
| Net Income to Company | 8.8 | 84.4 | -202.63 | -148.1 | -26.36 | 25.99 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 0.45 | -0.01 | Upgrade
|
| Net Income | 8.8 | 84.4 | -202.63 | -148.1 | -25.91 | 25.97 | Upgrade
|
| Net Income to Common | 8.8 | 84.4 | -202.63 | -148.1 | -25.91 | 25.97 | Upgrade
|
| Shares Outstanding (Basic) | 3,866 | 3,755 | 3,562 | 3,271 | 3,125 | 2,867 | Upgrade
|
| Shares Outstanding (Diluted) | 3,866 | 3,755 | 3,562 | 3,271 | 3,125 | 2,867 | Upgrade
|
| Shares Change (YoY) | 5.82% | 5.42% | 8.91% | 4.65% | 9.02% | 60.83% | Upgrade
|
| EPS (Basic) | 0.00 | 0.02 | -0.06 | -0.05 | -0.01 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.00 | 0.02 | -0.06 | -0.05 | -0.01 | 0.01 | Upgrade
|
| Free Cash Flow | 12.2 | 86.22 | -198.88 | -155.08 | -19.61 | 13.38 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | 0.02 | -0.06 | -0.05 | -0.01 | 0.00 | Upgrade
|
| Gross Margin | 78.81% | 76.40% | 67.43% | 69.41% | 57.95% | 57.56% | Upgrade
|
| Operating Margin | -3.76% | 1.88% | -15.95% | -18.95% | -55.17% | -43.32% | Upgrade
|
| Profit Margin | 14.91% | 111.70% | -338.70% | -558.41% | -323.69% | 281.82% | Upgrade
|
| Free Cash Flow Margin | 20.69% | 114.11% | -332.43% | -584.71% | -245.05% | 145.24% | Upgrade
|
| EBITDA | - | 1.45 | -9.42 | -4.53 | -3.85 | -3.31 | Upgrade
|
| EBITDA Margin | - | 1.93% | -15.74% | -17.08% | -48.11% | -35.91% | Upgrade
|
| D&A For EBITDA | - | 0.03 | 0.12 | 0.49 | 0.56 | 0.68 | Upgrade
|
| EBIT | -2.22 | 1.42 | -9.54 | -5.02 | -4.42 | -3.99 | Upgrade
|
| EBIT Margin | -3.76% | 1.88% | -15.95% | -18.95% | -55.17% | -43.32% | Upgrade
|
| Advertising Expenses | - | - | - | 1.61 | 0.65 | 0.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.